Excimer Light Versus Blue Light in Acne

Excimer Light Versus Blue Light in the Treatment of Inflammatory Acne, a Split Face Randomized Controlled Trial.

Status

Not yet recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06725303

Enrollment

Registered

2024-12-10

Start date

2025-06-01

Completion date

2025-10-01

Last updated

2025-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris

Brief summary

The aim is to assess the efficacy and safety of Excimer Light versus blue light in the treatment of inflammatory acne.

Detailed description

The use of new light energy in inflammatory acne

Interventions

DEVICEExcimer

Light energy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 25 Years

Healthy volunteers

Inclusion criteria

* Patients with mild to moderate inflammatory acne lesions

Exclusion criteria

* Pregnancy during the first trimester * Female patients with a medical history of PCO * Topical and systemic treatment within the last month and systemic retinoids for 6 months * Patients on systemic steroid treatment or hormonal therapy * Severe systemic illness or malignancy * Photosensitivity * Scarring acne vulgaris

Design outcomes

Primary

Measure	Time frame	Description
Number of comedones, papules and pustules	2 months	number of lesions

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026